CURD JOHN G has a total of 13 patent applications. Its first patent ever was published in 2003. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are GARCIA-ECHEVERRIA CARLOS, P ER FABR MEDIKAMAN and RECORDATI AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | WIPO (World Intellectual Property Organization) | 5 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds | |
#4 | Unspecified technologies | |
#5 | Peptides | |
#6 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Curd John G | 13 |
#2 | Keana John F W | 3 |
#3 | Grillo-Lopez Antonio J | 2 |
#4 | Westberg Paul B | 2 |
#5 | Lalani Alshad S | 2 |
#6 | Goodwin Bradford S | 2 |
#7 | Capizzi Robert L | 2 |
#8 | Kunkel Lori A | 1 |
#9 | Henner William D | 1 |
#10 | Henner W David | 1 |
Publication | Filing date | Title |
---|---|---|
WO2007095389A2 | Treatment of hyperproliferative diseases with camptothecine n-oxide and analogs | |
US2007275934A1 | Treatment of pancreatic cancer with active vitamin d compounds in combination with other treatments | |
US2005222190A1 | 1,4-bis-N-oxide azaanthracenediones and the use thereof | |
WO2004047673A2 | Treatment of liver disease with active vitamin d compounds |